Company / Return on Equity (ROE)
CONMED Corporation Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
4.5%
FY2025
5-year range
-10.8% / 13.8%
FY2021-FY2025
Trend
-66.9%
vs FY2024
Sector context
#68 of 147
Health Care
What the data says
At 4.5%, CONMED Corporation's return on equity (roe) ranks #68 of 147 in the Health Care sector. Return on Equity (ROE) has fluctuated over the past 10 years, ranging from -10.8% in FY2022 to 13.8% in FY2024.
Based on SEC 10-K filings.
4.5% in FY2025 with a 5-year CAGR of +3.2%.
Declined from 7.7% to 4.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +15.4pp
- 5-Year Change
- +3.2pp
- 10-Year Change
- -
Sector benchmark
#68 of 147 in Health CareTop 46% of 147This company 4.5% Sector average -3.3%
▼
+238.2% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 66.9% year-over-year.
- Currently 7.8pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2024.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 4.5% | -66.9% |
| FY2024 | 13.8% | +78.0% |
| FY2023 | 7.7% | +171.5% |
| FY2022 | -10.8% | -235.8% |
| FY2021 | 8.0% | +494.0% |
| FY2020 | 1.3% | -66.7% |
| FY2019 | 4.0% | -34.7% |
| FY2018 | 6.2% | -29.8% |
| FY2017 | 8.8% | +247.4% |
| FY2016 | 2.5% | -51.4% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026